- Home
- LVO vs HLVX Comparison
LVO vs HLVX Comparison
Compare LVO & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVO
- HLVX
- Stock Information
- Founded
- LVO 2009
- HLVX 2020
- Country
- LVO United States
- HLVX United States
- Employees
- LVO N/A
- HLVX N/A
- Industry
- LVO Restaurants
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- LVO Consumer Discretionary
- HLVX Health Care
- Exchange
- LVO Nasdaq
- HLVX Nasdaq
- Market Cap
- LVO 112.9M
- HLVX 93.1M
- IPO Year
- LVO N/A
- HLVX 2022
- Fundamental
- Price
- LVO $1.18
- HLVX $1.90
- Analyst Decision
- LVO Strong Buy
- HLVX Hold
- Analyst Count
- LVO 2
- HLVX 5
- Target Price
- LVO $2.75
- HLVX $2.33
- AVG Volume (30 Days)
- LVO 582.4K
- HLVX 324.9K
- Earning Date
- LVO 02-06-2025
- HLVX 11-07-2024
- Dividend Yield
- LVO N/A
- HLVX N/A
- EPS Growth
- LVO N/A
- HLVX N/A
- EPS
- LVO N/A
- HLVX N/A
- Revenue
- LVO $127,817,000.00
- HLVX N/A
- Revenue This Year
- LVO $5.30
- HLVX N/A
- Revenue Next Year
- LVO N/A
- HLVX N/A
- P/E Ratio
- LVO N/A
- HLVX N/A
- Revenue Growth
- LVO 17.10
- HLVX N/A
- 52 Week Low
- LVO $0.56
- HLVX $1.55
- 52 Week High
- LVO $2.15
- HLVX $20.22
- Technical
- Relative Strength Index (RSI)
- LVO 51.30
- HLVX 42.75
- Support Level
- LVO $1.12
- HLVX $1.87
- Resistance Level
- LVO $1.28
- HLVX $2.15
- Average True Range (ATR)
- LVO 0.15
- HLVX 0.09
- MACD
- LVO -0.02
- HLVX -0.02
- Stochastic Oscillator
- LVO 16.00
- HLVX 21.87
About LVO LiveOne Inc.
LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.